Hereditary hemorrhagic telangiectasia
آخر تحديث ٢٠ مايو ٢٠٢١
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
Hereditary hemorrhagic telangiectasia is a disorder that results in the development of multiple abnormalities in the blood vessels.
الوصف
Hereditary hemorrhagic telangiectasia is a disorder that results in the development of multiple abnormalities in the blood vessels.
In the circulatory system, blood carrying oxygen from the lungs is normally pumped by the heart into the arteries at high pressure. The pressure allows the blood to make its way through the arteries to the smaller vessels (arterioles and capillaries) that supply oxygen to the body's tissues. By the time blood reaches the capillaries, the pressure is much lower. The blood then proceeds from the capillaries into veins, through which it eventually returns to the heart.
In hereditary hemorrhagic telangiectasia, some arterial vessels flow directly into veins rather than into the capillaries. These abnormalities are called arteriovenous malformations. When they occur in vessels near the surface of the skin, where they are visible as red markings, they are known as telangiectases (the singular is telangiectasia).
Without the normal buffer of the capillaries, the blood moves from the arteries at high pressure into the thinner walled, less elastic veins. The extra pressure tends to strain and enlarge these blood vessels, and may result in compression or irritation of adjacent tissues and frequent episodes of severe bleeding (hemorrhage). Nosebleeds are very common in people with hereditary hemorrhagic telangiectasia, and more serious problems may arise from hemorrhages in the brain, liver, lungs, or other organs.
There are several forms of hereditary hemorrhagic telangiectasia, distinguished mainly by their genetic cause but with some differences in patterns of signs and symptoms. People with type 1 tend to develop symptoms earlier than those with type 2, and are more likely to have blood vessel malformations in the lungs and brain. Type 2 and type 3 may be associated with a higher risk of liver involvement. Women are more likely than men to develop blood vessel malformations in the lungs with type 1, and are also at higher risk of liver involvement with both type 1 and type 2. Individuals with any form of hereditary hemorrhagic telangiectasia, however, can have any of these problems.
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome is a condition that involves both arteriovenous malformations and a tendency to develop growths (polyps) in the gastrointestinal tract. Hereditary hemorrhagic telangiectasia types 1, 2 and 3 do not appear to increase the likelihood of such polyps.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
HHT
متلازمة أوسلر-ويبر-ريندو
Related patient information and medicines

Patient information leaflet
متلازمة أوسلر-ويبر-ريندو
Osler-Weber-Rendu syndrome is a disorder of the blood vessels that can cause excessive bleeding. Osler-Weber-Rendu syndrome is also called hereditary haemorrhagic telangiectasia. The abnormal blood vessels can cause bleeding both into the skin and inside your body. What is Osler-Weber-Rendu syndrome. People with Osler-Weber-Rendu syndrome can.

Patient information leaflet
الوردية
Rosacea symptoms Symptoms من الوردية include one or more of the following: Frequent flushing of your face, similar to blushing. This is often the first symptom and may be the only symptom for months or years before a... Tiny visible blood vessels on your face. This is also called telangiectasia. They can sometimes become quite prominent on your.

Patient information leaflet
النوبة الإقفارية العابرة
In the UK, about 1 in every 2000 people get a ... The true number might be higher, though. It's likely that some people have a TIA, but don't recognise it as one, or don't report it to their doctor. الأعراض من a transient ischaemic attack (TIA) ال الأعراض that develop depend on which part of the brain is affected. Different parts of the brain.

Patient information leaflet
السكتة الدماغية
Stroke symptoms The functions of the different parts of the body are controlled by different parts of the brain. So, the symptoms vary depending on which part of the brain is affected and on the size of the damaged area. In contrast, if a small branch artery is affected then only a small area of brain is damaged w... Stroke types There are two.

Patient information leaflet
طول النظر
The medical name for long-sightedness هو hypermetropia, sometimes called hyperopia. Eyesight problems, such as hypermetr... What causes hypermetropia. The causes of hypermetropia (long sight) are usually hereditary (genetic). Long sight can occur at any age but it tends to become more noticeable above the age of 40 years. In rare cases, long sight.

Patient information leaflet
مضادات التخثر
Having AF is one of the most common reasons for. Anticoagulants reduce the risk of having a stroke due to AF. Certain blood conditions which make blood تخرج خثرات دموية much more likely; for example, antiphospholipid syndrome or inherited thrombophilias. DOACs are much more commonl... In 2021, the UK's National Institute for Health and Care Excellence (NICE).
قراءة إضافية ومراجع
- Hereditary hemorrhagic telangiectasia; MedlinePlus, National Library of Medicine.
- Brady AP, Murphy MM, O'Connor TM. Hereditary haemorrhagic telangiectasia: a cause of preventable morbidity and mortality. Ir J Med Sci. 2009 Jun;178(2):135-46. doi: 10.1007/s11845-008-0220-5. Epub 2008 Oct 16.
- Dupuis-Girod S, Bailly S, Plauchu H. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost. 2010 Jul;8(7):1447-56. doi: 10.1111/j.1538-7836.2010.03860.x. Epub 2010 Mar 19.
- Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009 Jul;17(7):860-71. doi: 10.1038/ejhg.2009.35. Epub 2009 Apr 1.
- Grand'Maison A. Hereditary hemorrhagic telangiectasia. CMAJ. 2009 Apr 14;180(8):833-5. doi: 10.1503/cmaj.081739. No abstract available.
- McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med. 2011 Jul;13(7):607-16. doi: 10.1097/GIM.0b013e3182136d32.
- McDonald J, Wooderchak-Donahue W, VanSant Webb C, Whitehead K, Stevenson DA, Bayrak-Toydemir P. Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet. 2015 Jan 26;6:1. doi: 10.3389/fgene.2015.00001. eCollection 2015.
- Ragsdale JA. Hereditary hemorrhagic telangiectasia: from epistaxis to life-threatening GI bleeding. Gastroenterol Nurs. 2007 Jul-Aug;30(4):293-9; quiz 300-1. doi: 10.1097/01.SGA.0000287202.36602.fb.
- Rimmer J, Lund VJ. Hereditary haemorrhagic telangiectasia. Rhinology. 2015 Sep;53(3):195-203. doi: 10.4193/Rhino14.274.
- Robert F, Desroches-Castan A, Bailly S, Dupuis-Girod S, Feige JJ. Future treatments for hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2020 Jan 7;15(1):4. doi: 10.1186/s13023-019-1281-4.
- Sharathkumar AA, Shapiro A. Hereditary haemorrhagic telangiectasia. Haemophilia. 2008 Nov;14(6):1269-80. doi: 10.1111/j.1365-2516.2008.01774.x.
- Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010 Nov;24(6):203-19. doi: 10.1016/j.blre.2010.07.001. Epub 2010 Sep 25.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
٢٠ مايو ٢٠٢١ | أحدث إصدار
1 Feb 2007 | نُشر في الأصل
انضم إلى المحادثة
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.

اسأل، شارك، تواصل.
تصفح المناقشات، اطرح الأسئلة، وشارك التجارب عبر مئات المواضيع الصحية.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.